The 130th Annual Meeting of APHA |
4235.0: Tuesday, November 12, 2002: 4:30 PM-6:00 PM | |||
Oral | |||
| |||
Learning Objectives: (see individual abstracts) | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Gabrielle Denmead | |||
Determinants of cost of substance abuse treatment Donald S. Shepard, PhD, Aaron Beaston-Blaakman, MSW, MPA, Constance M. Horgan, ScD | |||
ADSS costs, program structure, and patient impact Albert M. Woodward, PhD, MBA, Ira E. Raskin, PhD | |||
Are incentive payments cost-effective in surveying a hard-to-interview population: The experience in ADSS Grant A. Ritter, PhD, Donald S. Shepard, PhD, Aaron Beaston-Blaakman, MSW, MPA, Sharon Reif, PhD, Constance M. Horgan, ScD | |||
Impact of ancillary services on substance abuse treatment outcomes Sharon Reif, PhD, Constance M. Horgan, ScD, Grant A. Ritter, PhD | |||
Substance abuse treatment: Labor market outcomes and criminal activity Regina H. Powers, PhD, JD | |||
Demonstration of public access to ADSS data through the Substance Abuse and Mental Health Data Archive (SAMHDA) Sarah Q. Duffy, PhD | |||
Organized by: | Alcohol, Tobacco, and Other Drugs | ||
CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work |